ELOS B Stock Overview
Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Elos Medtech AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 203.00 |
| 52 Week High | SEK 295.00 |
| 52 Week Low | SEK 185.00 |
| Beta | 1.12 |
| 1 Month Change | -5.14% |
| 3 Month Change | -8.14% |
| 1 Year Change | -17.31% |
| 3 Year Change | 96.14% |
| 5 Year Change | 195.92% |
| Change since IPO | 1,253.33% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)
Oct 11
Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?
May 23Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock
May 10Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)
Apr 17We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt
Mar 24Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?
Mar 11The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares
Feb 28Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?
Feb 24Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment
Feb 11When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?
Jan 31How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?
Jan 18
Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture
Jan 06Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?
Dec 26Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet
Dec 13Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 30Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 17Shareholder Returns
| ELOS B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0.5% | 0.9% | -1.6% |
| 1Y | -17.3% | -6.6% | 6.5% |
Return vs Industry: ELOS B underperformed the Swedish Medical Equipment industry which returned 2.5% over the past year.
Return vs Market: ELOS B underperformed the Swedish Market which returned 13.6% over the past year.
Price Volatility
| ELOS B volatility | |
|---|---|
| ELOS B Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.4% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: ELOS B has not had significant price volatility in the past 3 months.
Volatility Over Time: ELOS B's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1923 | 653 | Stefano Alfonsi | elosmedtech.com |
Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets. It offers implants, screws, plates, orthopedic and dental instruments, drills, pins and wires, dental prosthetics, disposable plastic products, HPLC fittings, and other medical plastic parts. The company also provides design and development, regulatory, prototyping, testing, OEM, process validation, and supply and inventory management, as well as design for manufacturing and engineering services.
Elos Medtech AB (publ) Fundamentals Summary
| ELOS B fundamental statistics | |
|---|---|
| Market cap | SEK 5.73b |
| Earnings (TTM) | SEK 54.95m |
| Revenue (TTM) | SEK 1.02b |
104.3x
P/E Ratio5.6x
P/S RatioIs ELOS B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELOS B income statement (TTM) | |
|---|---|
| Revenue | SEK 1.02b |
| Cost of Revenue | SEK 676.62m |
| Gross Profit | SEK 341.02m |
| Other Expenses | SEK 286.07m |
| Earnings | SEK 54.95m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 29, 2024
| Earnings per share (EPS) | 1.95 |
| Gross Margin | 33.51% |
| Net Profit Margin | 5.40% |
| Debt/Equity Ratio | 51.6% |
How did ELOS B perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield15%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/21 17:19 |
| End of Day Share Price | 2023/12/19 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Elos Medtech AB (publ) is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oskar Vikström | ABG Sundal Collier Sponsored |
| Andreas Kvist | Redeye |